Literature DB >> 12750858

A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes.

Wafaa M Bassuny1, Kenji Ihara2, Yuka Sasaki2, Ryuichi Kuromaru2, Hitoshi Kohno3, Nobuo Matsuura4, Toshiro Hara2.   

Abstract

FOXP3/Scurfin, a member of forkhead/winged-helix proteins, is involved in the regulation of T-cell activation, and essential for normal immune homeostasis. The FOXP3/Scurfin gene is located on chromosome Xp11.23, which includes one of the type 1 diabetes susceptible loci. Therefore, we investigated whether the human FOXP3/Scurfin gene might be a new candidate gene for type 1 diabetes. We first screened the human FOXP3/Scurfin gene for microsatellite and single nucleotide polymorphisms. Next, we performed an association study between the FOXP3/Scurfin gene and type 1 diabetes. Then, the evaluation of promoter/enhancer activity of the intron with (GT)(n) polymorphism was performed by dual luciferase reporter assay. We demonstrated two regions contained microsatellite polymorphisms; one was (GT)(n), located on intron zero and the other (TC)(n) on intron 5, which were under linkage-disequilibrium. The (GT)(15) allele showed a significantly higher frequency in patients with type 1 diabetes than in controls (43.1% vs 32.6%, P=0.0027). The genotype frequencies of (GT)(15)/(GT)(15) in female patients and of (GT)(15) in male patients tended to be higher than those in female ( P=0.064) and male ( P=0.061) controls, respectively. A significant difference in the enhancer activity between (GT)(15) and (GT)(16) dinucleotide repeats was detected. In conclusion, the FOXP3/Scurfin gene appears to confer a significant susceptibility to type 1 diabetes in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750858     DOI: 10.1007/s00251-003-0559-8

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  40 in total

Review 1.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

2.  Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.

Authors:  L D Poulton; M J Smyth; C G Hawke; P Silveira; D Shepherd; O V Naidenko; D I Godfrey; A G Baxter
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

Review 3.  T-cell education in autoimmune diabetes: teachers and students.

Authors:  Judith G M Rosmalen; Willem van Ewijk; Pieter J M Leenen
Journal:  Trends Immunol       Date:  2002-01       Impact factor: 16.687

4.  The amount of scurfin protein determines peripheral T cell number and responsiveness.

Authors:  R Khattri; D Kasprowicz; T Cox; M Mortrud; M W Appleby; M E Brunkow; S F Ziegler; F Ramsdell
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 5.  Genetic linkage and association studies of Type I diabetes: challenges and rewards.

Authors:  L L Field
Journal:  Diabetologia       Date:  2002-01       Impact factor: 10.122

6.  Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.

Authors:  R S Abraham; L Wen; E V Marietta; C S David
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

7.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

Authors:  S B Wilson; S C Kent; K T Patton; T Orban; R A Jackson; M Exley; S Porcelli; D A Schatz; M A Atkinson; S P Balk; J L Strominger; D A Hafler
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

Review 8.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

9.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

10.  A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients.

Authors:  F Cucca; J V Goy; Y Kawaguchi; L Esposito; M E Merriman; A J Wilson; H J Cordell; S C Bain; J A Todd
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

View more
  42 in total

1.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

2.  PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children.

Authors:  Ronghua Ni; Kenji Ihara; Kenichi Miyako; Ryuichi Kuromaru; Mika Inuo; Hitoshi Kohno; Toshiro Hara
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

3.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

4.  Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice.

Authors:  Qanhui Zheng; Yamei Xu; Yanlong Liu; Baojun Zhang; Xiaokun Li; Feng Guo; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2009-10-20       Impact factor: 4.599

5.  Novel and functional regulatory SNPs in the promoter region of FOXP3 gene in a Gabonese population.

Authors:  Susanne A Hanel; T P Velavan; Peter G Kremsner; Jürgen F J Kun
Journal:  Immunogenetics       Date:  2011-04-07       Impact factor: 2.846

6.  Dissecting the role of the FOXP3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: a genetic and functional analysis.

Authors:  Cheuk Wun Li; Erlinda Concepcion; Yaron Tomer
Journal:  Gene       Date:  2014-12-03       Impact factor: 3.688

7.  Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families.

Authors:  Maria Justina B Villano; Amanda K Huber; David A Greenberg; Brian K Golden; Erlinda Concepcion; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

8.  The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

Authors:  C Julier; B Akolkar; P Concannon; G Morahan; C Nierras; A Pugliese
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

9.  Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1.

Authors:  Ushma R Jag; Jiri Zavadil; Frederick M Stanley
Journal:  Mol Endocrinol       Date:  2009-07-16

10.  Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Yuya Hashimura; Kandai Nozu; Hirokazu Kanegane; Toshio Miyawaki; Akira Hayakawa; Norishige Yoshikawa; Koichi Nakanishi; Minoru Takemoto; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.